Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new microUS. The study is looking to identify the most effective imaging modality to help guide whether you progress to have a prostate biopsy.

Additional locations may be listed on ClinicalTrials.gov for NCT06626022.

See trial information on ClinicalTrials.gov for a list of participating sites.

Trial PhasePhase III

Trial Typescreening

Lead OrganizationUniversity of Alberta Hospital

• Primary IDHREBA.CC-24-0325
• Secondary IDsNCI-2025-04313
• ClinicalTrials.gov IDNCT06626022